Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1947-1954

  Zhou, Tianlun ^a,b   Saputelli, Jeffry ^a   Aldrich, Carol E ^a   Deslauriers, Manon ^c   Condreay, Lynn D ^c   Mason, William S ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA POLYMERASE; LAMIVUDINE; VIRUS DNA;

AMINO ACID SEQUENCE; ANIMAL DISEASE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG RESISTANCE; GENETIC TRANSFECTION; HEPATITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS MUTATION; WOODCHUCK;

EID: 0032817797     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1947     Document Type: Article

References (29)

1. Aldrich, C. E., L. Coates, T. T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. 1989. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology 172:247-252.
2. Allen, M. I., M. Deslauriers, C. W. Andrews, G. A. Tipples, K.-A. Walters, D. L. J. Tyrrell, N. Brown, and L. D. Condreay. 1997. Identification and characterization of mutations in HBV resistant to lamivudine. Hepatology 27:1670-1677.
3. Bartholomeusz, A., L. C. Groenen, and S. A. Locarnini. 1997. Clinical experience with famciclovir against hepatitis B virus. Intervirology 40:337-342.
4. Chayama, K., Y. Suzuki, M. Kobayashi, M. Kobayashi, A. Tsubota, M. Hashimolo, Y. Miyano, H. Koike, M. Kobayashi, I. Koida, Y. Arase, S. Saitoh, N. Murashima, K. Ikeda, and H. Kumada. 1998. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type virus after cessation of therapy. Hepatology 27:1711-1716.
5. Cohen, J. I., R. H. Miller, B. Rosenblum, K. Denniston, J. L. Gerin, and R. H. Purcell. 1988. Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome. Virology 162:12-20.
6. Di, Q., J. Summers, J. B. Burch, and W. S. Mason. 1997. Major differences between WHV and HBV in the regulation of transcription. Virology 229: 25-35.
7. Fischer, K. P., and D. L. Tyrrell. 1996. Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(-)-β-L-2′,3′-dideoxy-3′-thiacytidine] in vitro. Antimicrob. Agents Chemother. 40:1957-1960.
8. Genovesi, E. V., L. Lamb, I. Medina, D. Taylor, M. Seifer, S. Innaimo, R. J. Colonno, D. N. Standring, and J. M. Clark. 1998. Efficacy of the carbocyclic 2′-carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection. Antimicrob. Agents Chemother. 42: 3209-3217.
9. Honkoop, P., H. G. Niesters, R. A. de Man, A. D. Osterhaus, and S. W. Schalm. 1997. Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J. Hepatol. 26:1393-1395.
10. Hoofnagle, J. H., and A. M. DiBisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
11. Horton, R. M., Z. L. Cai, S. N. Ho, and L. R. Pease. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8:528-535.
12. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. A. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
13. Huang, M. J., and J. Summers. 1991. Infection initiated by the RNA pregenome of a DNA virus. J. Virol. 65:5435-5439.
14. Kodama, K., N. Ogasawara, H. Yoshikawa, and S. Murakami. 1985. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J. Virol. 54:978-986.
15. Ling, R., D. Mutimer, M. Ahmed, E. H. Boxall, E. Elias, G. M. Dusheiko, and T. J. Harrison. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
16. Mason, W. S., C. Aldrich, J. Summers, and J. M. Taylor. 1982. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc. Natl. Acad. Sci. USA 79:3997-4001.
17. Mason, W. S., J. Cullen, G. Moraleda, J. Saputelli, C. E. Aldrich, D. S. Miller, B. Tennant, L. Frick, D. Averett, L. D. Condreay, and A. R. Jilbert. 1998. Lamivudine therapy of WHV infected woodchucks. Virology 245:18-32.
18. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing heptocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
19. Niesters, H. G., P. Honkoop, E. B. Haagsma, R. A. de Man, S. W. Schalm, and A. D. Osterhaus. 1998. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J. Infect. Dis. 177:1382-1385.
20. Nowak, M. A., S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, and H. McDade. 1996. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93:4398-4402.
21. Perrillo, R. P., E. R. Schiff, G. L. Davis, H. C. Bodenheimer, K. Lindsay, J. Payne, J. L. Dienstag, C. O'Brien, C. Tamburro, I. M. Jacobson, R. Sampliner, D. Feit, J. Lefkowitch, M. Kuhns, C. Meschievitz, B. Sanghvi, J. Albrecht, and A. Gibas. 1990. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N. Engl. J. Med. 323:295-301.
22. Rajagopalan, P., F. D. Boudinot, C. K. Chu, B. C. Tennant, B. H. Baldwin, and R. F. Schinazi. 1996. Pharmacokinetics of (-)-2′-3′-dideoxy-3′-thiacytidine in woodchucks. Antimicrob. Agents Chemother. 40:642-645.
23. Schuurman, R., M. Nijhius, R. van Leeumen, P. Schipper, D. de Jong, P. Collis, S. A. Danner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type I RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine. J. Infect. Dis. 171:1411-1419.
24. Seeger, C., B. Baldwin, and B. C. Tennant. 1989. Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts. J. Virol. 63:4665-4669.
25. Tipples, G. A., M. M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. J. Tyrrell. 1996. Mutation in HBV DNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
26. van der Eb, A. J., and F. L. Graham. 1980. Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65:826-839.
27. Wahl, G. M., M. Stern, and G. R. Stark. 1979. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl paper and rapid hybridization by using dextran sulfate. Proc. Natl. Acad. Sci. USA 76:3683-3687.
28. Yaginuma, K., Y. Shirakata, M. Kobayashi, and K. Koike. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. USA 84:2678-2682.
29. Yang, W., W. S. Mason, and J. Summers. 1996. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J. Virol. 70:4567-4575.